N Engl J Med 379 (2): 122-137, 2018.[PUBMED Abstract] Kim HA, Lee JW, Nam SJ, et al.: Adding Ovarian Suppression to Tamoxifen for Premenopausal Breast Cancer: A Randomized Phase III Trial.
J Clin Oncol 38 (5): 434-443, 2020.[PUBMED Abstract] Gnant M, Mlineritsch B, Stoeger H, et al.: Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 62-month follow-up from the ABCSG-12 randomised trial.
Lancet Oncol 12 (7): 631-41, 2011.[PUBMED Abstract] Pagani O, Regan MM, Walley BA, et al.: Adjuvant exemestane with ovarian suppression in premenopausal breast cancer.